Discover Oncology, formerly Hormones and Cancer, is a bimonthly peer-reviewed medical journal covering research on all aspects of hormone action on cancer. It was established in 2010 and is published by Springer Science + Business Media on behalf of The Endocrine Society. The editor-in-chief is Carol A. Lange (University of Minnesota).
DiscoverOncology, formerly Hormones and Cancer, is a bimonthly peer-reviewed medical journal covering research on all aspects of hormone action on cancer...
The history of cancer describes the development of the field of oncology and its role in the history of medicine. The earliest known descriptions of cancer...
susceptible cancers. The subspecialty of oncology concerned with radiotherapy is called radiation oncology. A physician who practices in this subspecialty...
Clovis Oncology is an American pharmaceutical company which mainly markets products for treatment in oncology. Clovis was founded in 2009 and is headquartered...
Endocrine Society publishes the following journals:[citation needed] DiscoverOncology Endocrine Reviews Endocrinology Journal of Clinical Endocrinology...
Takeda Oncology (originally Millennium Pharmaceuticals) is a biopharmaceutical company based in Cambridge, Massachusetts. It is a fully owned subsidiary...
Verastem Oncology (Verastem Inc) is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston...
colonic origin: a consensus statement. Society of Surgical Oncology". Annals of Surgical Oncology. 14 (1): 128–133. doi:10.1245/s10434-006-9185-7. PMID 17072675...
Mellman is an American cell biologist who discovered endosomes. He serves as Vice President of Research Oncology at Genentech in South San Francisco, California...
company announced a collaboration with Xencor on 6 early stage immuno-oncology and inflammation programmes. As part of the deal Amgen will pay $45 million...
precision medicine that addresses cancer is referred to as "precision oncology". The field of precision medicine that is related to psychiatric disorders...
(eds.). ASCO-SEP : Medical Oncology Self-Evaluation Program (7th ed.). Alexandria, VA: American Society of Clinical Oncology. ISBN 978-0-9983747-4-1. OCLC 1080368315...
breakup fee. On March 4, 2015, AbbVie announced its agreement to acquire oncology firm Pharmacyclics and its treatment for blood cancers, ibrutinib; AstraZeneca...
specifically devoted to pharmacotherapy for cancer, which is called medical oncology. The term chemotherapy has come to connote non-specific usage of intracellular...
cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684". Journal of Clinical Oncology. 14 (1): 7–17. doi:10.1200/JCO.1996.14.1.7. PMID 8558223...
of a multidisciplinary team including specialists in several aspects of oncology, and is, therefore, best conducted in larger centers. Surgery with the...
Indiana University Medical Center, followed by a fellowship in Hematology/Oncology at the M.D. Anderson Hospital Tumor Institute in Houston, Texas. He returned...
from a Combined Pediatric Oncology Group and Children's Cancer Group study". The American Journal of Pediatric Hematology/Oncology. 15 (4): 406–409. PMID 7692755...
combination therapy in oncology. The National Cancer Institute has recently highlighted combination therapy as a top research priority in oncology. Combination...
from the international lymphoma radiation oncology group (ILROG)". International Journal of Radiation Oncology, Biology, Physics. 89 (4): 854–62. doi:10...
The Alliance for Clinical Trials in Oncology is a national clinical trials network sponsored by the National Cancer Institute (NCI) that consists of about...
potential clinical applications in a range of disease areas including oncology, immuno-oncology, ophthalmology, and infectious diseases. Molecular Partners currently...
as injected radiopharmaceuticals or from external beam radiotherapy in oncology. Radioisotopes such as the positron emitters 18F and 13N or beta emitters...
European Oncology Review 2005; pp. 1–6. Chan JA, Kulke MH (May 2009). "Progress in the treatment of neuroendocrine tumors". Current Oncology Reports....
collaboration with Regeneron Pharmaceuticals to discover, develop, and commercialize new immuno-oncology drugs, which could generate more than $2 billion...
Global Information